Search Results - "Barnes, D S"

Refine Results
  1. 1

    Spectrum occupancy investigation: Measurements in South Africa by Barnes, S.D., Jansen van Vuuren, P.A., Maharaj, B.T.

    “…•Spectrum measurements were taken for the UHF and GSM bands over a six week period.•An improved method for statistically determining spectrum occupancy was…”
    Get full text
    Journal Article
  2. 2

    Outcome of de novo hepatitis C virus infection in heart transplant recipients by ONG, J. P, BARNES, D. S, SMEDIRA, N, MCCARTHY, P, YOUNOSSI, Z. M, GRAMLICH, T, YEN-LIEBERMAN, B, GOORMASTIC, M, SHEFFIELD, C, HOERCHER, K, STARLING, R, YOUNG, J

    Published in Hepatology (Baltimore, Md.) (01-11-1999)
    “…The outcome of de novo hepatitis C virus (HCV) infection in heart transplant recipients of HCV-antibody positive organs is not known. The aim of the study was…”
    Get full text
    Journal Article
  3. 3

    Historical perspectives on the etiology of tuberculosis by Barnes, David S

    Published in Microbes and infection (01-04-2000)
    “…Robert Koch's 1882 demonstration that the tubercle bacillus was the true cause of tuberculosis established a new understanding of causation in medicine. This…”
    Get full text
    Journal Article
  4. 4

    The prevalence of coronary artery disease in liver transplant candidates over age 50 by Carey, W D, Dumot, J A, Pimentel, R R, Barnes, D S, Hobbs, R E, Henderson, J M, Vogt, D P, Mayes, J T, Westveer, M K, Easley, K A

    Published in Transplantation (27-03-1995)
    “…The prevalence of angiographically proven coronary artery disease (CAD) in adults with end-stage liver disease who undergo evaluation for liver transplantation…”
    Get more information
    Journal Article
  5. 5

    Immunogenicity of hepatitis A vaccine in decompensated liver disease by Dumot, John A, Barnes, David S, Younossi, Zobair, Gordon, Steven M, Avery, Robin K, Domen, Ronald E, Henderson, Michael J, Carey, William D

    Published in The American journal of gastroenterology (01-06-1999)
    “…Hepatitis A can cause decompensation and death in patients with previous liver injury. The hepatitis A vaccine is recommended for patients with chronic liver…”
    Get full text
    Journal Article
  6. 6

    Control of intraocular pressure elevations after argon laser trabeculoplasty: comparison of brimonidine 0.2% to apraclonidine 1.0 by Barnes, S D, Campagna, J A, Dirks, M S, Doe, E A

    Published in Ophthalmology (Rochester, Minn.) (01-10-1999)
    “…To determine whether brimonidine 0.2% can control intraocular pressure (IOP) spikes as well as apraclonidine 1.0% can in those patients undergoing argon laser…”
    Get more information
    Journal Article
  7. 7

    Spectral occupation of TV broadcast bands: Measurement and analysis by Barnes, S.D., Botha, P.R., Maharaj, B.T.

    “…•The findings of a TV broadcast spectrum measurement campaign are presented.•Data is compared to both actual TV channel allocations and a geo-location…”
    Get full text
    Journal Article
  8. 8

    The utility of the 13C‐galactose breath test as a measure of liver function by Saadeh, S., Behrens, P. W., Parsi, M. A., Carey, W. D., Connor, J. T., Grealis, M., Barnes, D. S.

    Published in Alimentary pharmacology & therapeutics (15-11-2003)
    “…Summary Background : The 13C‐galactose breath test has been reported to be an accurate, non‐invasive method for the assessment of liver function. Aims : To…”
    Get full text
    Journal Article
  9. 9

    Cardiac rhythm disturbances among children with idiopathic congenital central hypoventilation syndrome by Silvestri, Jean M., Hanna, Brian D., Volgman, Annabelle S., Jones, Paul J., Barnes, Steven D., Weese-Mayer, Debra E.

    Published in Pediatric pulmonology (01-05-2000)
    “…The objective of this study was to determine whether subjects with congenital central hypoventilation syndrome (CCHS) had an increased frequency of cardiac…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Pretreatment With Methylprednisolone to Prevent Ercp-Induced Pancreatitis: A Randomized, Multicenter, Placebo-Controlled Clinical Trial by DUMOT, J. A, CONWELL, D. L, PONSKY, J. L, ZUCCARO, G, O'CONNOR, J. B, FERGUSON, D. R, VARGO, J. J, BARNES, D. S, SHAY, S. S, STERLING, M. J, HORTH, K. S, ISSA, K

    Published in The American journal of gastroenterology (01-01-1998)
    “…Pancreatitis remains the major complication of endoscopic retrograde cholangiopancreatography (ERCP). Uncontrolled data suggest a lower incidence of…”
    Get full text
    Journal Article
  12. 12

    Nevoid basal cell carcinoma syndrome in a black child by Hall, Jenifer, Johnston, Kay A., McPhillips, John P., Barnes, Scott D., Elston, Dirk M.

    “…Nevoid basal cell carcinoma syndrome (NBCCS) is rare in black persons. We describe an 11-year-old black boy with NBCCS who presented with exotropia and a…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Halothane Enhances Pulmonary Artery Endothelial Eicosanoid Release by Barnes, Steve D., Martin, Lynn D., Wetzel, Randall C.

    Published in Anesthesia and analgesia (01-12-1992)
    “…To determine whether anesthetics alter endothelial eicosanoid release, cultured bovine pulmonary artery endothelial cells were studied during constant flow and…”
    Get full text
    Journal Article
  18. 18

    The pediatric cardiology pharmacopoeia by Abdulla, R, Young, S, Barnes, S D

    Published in Pediatric cardiology (01-05-1997)
    “…Keeping up with a rapidly growing list of medications has always been a breathtaking and, at times, impossible task to master. Contrary to common belief, the…”
    Get full text
    Journal Article
  19. 19
  20. 20

    A prospective, double-blind trial of somatostatin analog (octreotide) versus glucagon for the inhibition of small intestinal motility during endoscopic retrograde cholangiopancreatography by Van Dam, Jacques, Catalano, Marc F., Ferguson, D.Roy, Barnes, David S., Zuccaro, Gregory, Sivak, Michael V.

    Published in Gastrointestinal endoscopy (01-10-1995)
    “…Background: Glucagon is effective when used as an antimotility agent during ERCP, but at high doses it may cause nausea and vomiting. Octreotide acetate, a…”
    Get full text
    Journal Article